» Articles » PMID: 18445079

Altered Adhesive Structures and Their Relation to RhoGTPase Activation in Merlin-deficient Schwannoma

Overview
Journal Brain Pathol
Date 2008 May 1
PMID 18445079
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Schwannomas are Schwann cell tumors of the nervous system that occur spontaneously and in patients with neurofibromatosis 2 (NF2) and lack the tumor suppressor merlin. Merlin is known to bind paxillin, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix. Moreover, merlin-deficient Schwannomas show pathological adhesion to the extracellular matrix making the characterization of focal contacts indispensable. Using our Schwannoma in vitro model of human primary Schwann and Schwannoma cells, we here show that Schwannoma cells display an increased number of mature and stable focal contacts. In addition to an involvement of RhoA signaling via the Rho kinase ROCK, Rac1 plays a significant role in the pathological adhesion of Schwannoma cells. The Rac1 guanine exchange factor- beta-Pix, localizes to focal contacts in human primary Schwannoma cells, and we show that part of the Rac1 activation, an effect of merlin-deficiency, occurs at the level of focal contacts in human primary Schwannoma cells. Our results help explaining the pathological adhesion of Schwannoma cells, further strengthen the importance of RhoGTPase signaling in Schwannoma development, and suggest that merlin's role in tumor suppression is linked to focal contacts.

Citing Articles

Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis.

Guo C Front Cell Dev Biol. 2022; 10:862791.

PMID: 35774228 PMC: 9237464. DOI: 10.3389/fcell.2022.862791.


Proteomic screening identifies PML/p53 axis as a potential treatment target of facial nerve schwannomas.

Wang Z, Chen H, Xue L, He W, Jiang L, Wang Z Am J Transl Res. 2020; 12(8):4237-4250.

PMID: 32913501 PMC: 7476122.


YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.

White S, Avantaggiati M, Nemazanyy I, Di Poto C, Yang Y, Pende M Dev Cell. 2019; 49(3):425-443.e9.

PMID: 31063758 PMC: 6524954. DOI: 10.1016/j.devcel.2019.04.014.


p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during tumor progression.

Li X, Chen H, Xue L, Pang X, Zhang X, Zhu Z Oncol Lett. 2017; 14(2):2223-2231.

PMID: 28789444 PMC: 5530008. DOI: 10.3892/ol.2017.6445.


Cellular prion protein (PrP) in the development of Merlin-deficient tumours.

Provenzano L, Ryan Y, Hilton D, Lyons-Rimmer J, Dave F, Maze E Oncogene. 2017; 36(44):6132-6142.

PMID: 28692055 DOI: 10.1038/onc.2017.200.


References
1.
Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann C, Giovannini M . A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor. Cancer J. 2004; 10(1):20-6. DOI: 10.1097/00130404-200401000-00006. View

2.
Utermark T, Schubert S, Hanemann C . Rearrangements of the intermediate filament GFAP in primary human schwannoma cells. Neurobiol Dis. 2005; 19(1-2):1-9. DOI: 10.1016/j.nbd.2004.11.015. View

3.
Dickersin G . The electron microscopic spectrum of nerve sheath tumors. Ultrastruct Pathol. 1987; 11(2-3):103-46. DOI: 10.3109/01913128709048319. View

4.
Utermark T, Kaempchen K, Hanemann C . Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins. Brain Pathol. 2003; 13(3):352-63. PMC: 8095832. DOI: 10.1111/j.1750-3639.2003.tb00034.x. View

5.
Benninger Y, Thurnherr T, Pereira J, Krause S, Wu X, Chrostek-Grashoff A . Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development. J Cell Biol. 2007; 177(6):1051-61. PMC: 2064365. DOI: 10.1083/jcb.200610108. View